Related Experiment Video
Updated: Mar 29, 2026
09:29
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
2.9K
Does retigabine affect the development of alcohol dependence?--A pharmaco-EEG study
Ewa Zwierzyńska1, Dariusz Andrzejczak1, Bogusława Pietrzak1
1Department of Pharmacodynamics, Medical University of Łódź, Muszyńskiego 1, 90-151 Łódź, Poland.
Neuroscience Letters
|November 25, 2015
Summary
Retigabine shows promise in treating alcohol dependence by reducing ethanol-induced brain changes during administration and withdrawal. This antiepileptic drug may offer a new therapeutic avenue for managing alcohol use disorder.
Area of Science:
- Neuroscience
- Pharmacology
- Addiction Medicine
Background:
- Alcohol dependence is a significant health issue with complex neurobiological underpinnings.
- Current treatments for alcohol dependence have limitations, necessitating the exploration of novel therapeutic agents.
- Antiepileptic drugs are being investigated for their potential to modulate brain activity affected by alcohol.
Purpose of the Study:
- To investigate the effect of retigabine, an antiepileptic drug, on the development of alcohol dependence.
- To examine the impact of retigabine on acute alcohol withdrawal syndrome.
- To assess the neurophysiological changes induced by ethanol and modulated by retigabine in specific brain regions.
Main Methods:
- A pharmaco-EEG (electroencephalography) method was employed in rabbits.
- Retigabine was administered orally (p.o.) at 5mg/kg/day alongside ethanol ad libitum for six weeks.
- Brain activity was monitored in the midbrain reticular formation, hippocampus, and frontal cortex during ethanol administration and a subsequent two-week abstinence period.
Main Results:
- Ethanol administration induced significant changes in brain bioelectric activity, indicating an inhibitory effect on neural structures within two weeks.
- During the abstinence period, significant neuronal hyperactivity was observed, particularly in the midbrain reticular formation and hippocampus.
- Retigabine administration demonstrably decreased ethanol-induced changes in brain activity during both the intoxication and abstinence phases.
Conclusions:
- Retigabine exhibits a modulatory effect on ethanol-induced neurophysiological changes associated with alcohol dependence.
- The drug's impact on the hippocampus is highlighted as a potentially significant mechanism in its therapeutic action for alcohol dependence.
- These findings suggest retigabine as a potential therapeutic candidate for alcohol dependence treatment.
Related Concept Videos
01:20Antiepileptic Drugs: Potassium Channel Activators
956
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
956
01:27CNS Depressants: Alcohol and Nicotine
1.6K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.6K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.6K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.1K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
01:14Antiepileptic Drugs: Glutamate Antagonists
1.2K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.2K
01:17Drug Dependence
1.9K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.9K